Probiotix HealthFRA:X90 -0.68% ROE % is -131.88% as of Dec. 2025. The stock has 1 warning sign investors should review. Among 1,255 Biotechnology companies, Probiotix Health ranks worse than 66.37% on this metric.
The historical rank and industry rank for Probiotix Health's ROE % or its related term are showing as below:
FRA:X90'
s ROE % Range Over the Past 10 Years
Min: -73.26 Med: -49.04 Max: -42.42
Current: -71.76
During the past 7 years, Probiotix Health's highest ROE % was -42.42%. The lowest was -73.26%. And the median was -49.04%.
FRA:X90's ROE % is ranked worse than 66.37% of 1255
companies
in the Biotechnology industry
Industry Median: -38.18
vs FRA:X90: -71.76
Probiotix Health (FRA:X90) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Probiotix Health ROE % Related Terms
Probiotix Health ROE % Historical Data
* Premium members only.
The historical data trend for Probiotix Health's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Probiotix Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Probiotix Health ROE % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Probiotix Health's ROE % distribution charts can be found below:
* The bar in red indicates where Probiotix Health's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Probiotix Health (FRA:X90) has a ROE % of -131.88% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Probiotix Health and its competitors. According to the industry distribution chart, Probiotix Health ranks #833 out of 1255 companies in the Biotechnology industry, placing it in the top 66.4%.
Is Probiotix Health's ROE % too high?
Probiotix Health's current ROE % is -131.88%. Based on the distribution chart, Probiotix Health ranks #833 out of 1255 companies in the Biotechnology industry, which is below the industry midpoint.
How does Probiotix Health's ROE % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Probiotix Health ranks #833 out of 1255 companies for ROE %. This places Probiotix Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Biotechnology company?
A good ROE % depends on the Biotechnology industry context. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Probiotix Health and its competitors. Probiotix Health's current ROE % is -131.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Probiotix Health stock overvalued right now?
Probiotix Health (FRA:X90) has a current ROE % of -131.88%. The stock's GF Value™ is €0.09, compared to a current price of €0.07 — trading 18.3% below its estimated fair value. The current ROE % is -131.88%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Probiotix Health (FRA:X90), the current ROE % is -131.88% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Probiotix Health PLC is a life sciences company that develops probiotics to tackle cardiovascular disease and other lifestyle conditions that are affecting growing numbers of people across the world. The company has one class of business, in three geographical areas, being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry. Its geographical segments include the United Kingdom, the United States, and the Rest of the World. It generates the majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:X90 has been successfully added to your 